Related references
Note: Only part of the references are listed.The cAMP-phosphodiesterase 4 (PDE4) controls β-adrenoceptor- and CFTR-dependent saliva secretion in mice
Abigail Boyd et al.
BIOCHEMICAL JOURNAL (2021)
Inhibition of cAMP-phosphodiesterase 4 (PDE4) potentiates the anesthetic effects of Isoflurane in mice
Ileana Aragon et al.
BIOCHEMICAL PHARMACOLOGY (2021)
The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
Dean Paes et al.
PHARMACOLOGICAL REVIEWS (2021)
Cyclic nucleotide phosphodiesterases: New targets in the metabolic syndrome?
Claire Lugnier et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Advances in the Development of Phosphodiesterase-4 Inhibitors
Ting Peng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Phosphodiesterase 4B: Master Regulator of Brain Signaling
Amy J. Tibbo et al.
CELLS (2020)
PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice
Will McDonough et al.
FASEB JOURNAL (2020)
Inhibition of type 4 cAMP-phosphodiesterases (PDE4s) in mice induces hypothermia via effects on behavioral and central autonomous thermoregulation
Will McDonough et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS
Shradha Bodkhe et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling
Eirini Vagena et al.
TRANSLATIONAL PSYCHIATRY (2019)
Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
George S. Baillie et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Validation of the xylazine/ketamine anesthesia test as a predictor of the emetic potential of pharmacological compounds in rats
Ellis Nelissen et al.
NEUROSCIENCE LETTERS (2019)
Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice
Chong Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Heng Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
Selective Inhibition of Phosphodiesterases 4A, B, C and D Isoforms in Chronic Respiratory Diseases: Current and Future Evidences
Sonia Contreras et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective
Pierre Bobin et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2016)
Thermoregulatory disorders and illness related to heat and cold stress
William P. Cheshire
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2016)
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Rudolph M. Navari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studies
P. Chervinsky et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
Discovery of triazines as selective PDE4B versus PDE4D inhibitors
Timothy J. Hagen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model
S. D. Boomkamp et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Advances in targeting cyclic nucleotide phosphodiesterases
Donald H. Maurice et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior
Rolf T. Hansen et al.
PSYCHOPHARMACOLOGY (2014)
Thermoregulatory correlates of nausea in rats and musk shrews
Sukonthar Ngampramuan et al.
ONCOTARGET (2014)
Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signaling
Charles C. Horn
EXPERIMENTAL BRAIN RESEARCH (2014)
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
S.-L.Catherine Jin et al.
Biomedical Journal (2014)
PDE4 as a target for cognition enhancement
Wito Richter et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Evaluation of the Therapeutic Index of a Novel Phosphodiesterase 4B-Selective Inhibitor Over Phosphodiesterase 4D in Mice
Osamu Suzuki et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2013)
Correction: Why Can’t Rodents Vomit? A Comparative Behavioral, Anatomical, and Physiological Study
Charles C. Horn et al.
PLoS One (2013)
Metoclopramide and Homicidal Ideation: A Case Report and Literature Review
Robert J. Surawski et al.
PSYCHOSOMATICS (2013)
PDE Inhibition and cognition enhancement
Arjan Blokland et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Phosphodiesterase 4B in the cardiac L-type Ca2+ channel complex regulates Ca2+ current and protects against ventricular arrhythmias in mice
Jerome Leroy et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Phosphodiesterase-4D Knock-Out and RNA Interference-Mediated Knock-Down Enhance Memory and Increase Hippocampal Neurogenesis via Increased cAMP Signaling
Yun-Feng Li et al.
JOURNAL OF NEUROSCIENCE (2011)
Phosphodiesterase 4B is essential for TH2-cell function and development of airway hyperresponsiveness in allergic asthma
S. -L. Catherine Jin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
Alex B. Burgin et al.
NATURE BIOTECHNOLOGY (2010)
The preclinical pharmacology of roflumilast - A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
Armin Hatzelmann et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
Miles D. Houslay
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Identification of PDE4B Over 4D subtype-selective inhibitors revealing an unprecedented binding mode
Michael Kranz et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Discovery of selective PDE4B inhibitors
Kenji Naganuma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Antidepressant- and Anxiolytic-like Effects of the Phosphodiesterase-4 Inhibitor Rolipram on Behavior Depend on Cyclic AMP Response Element Binding Protein-Mediated Neurogenesis in the Hippocampus
Yun-Feng Li et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
Olga A. H. Reneerkens et al.
PSYCHOPHARMACOLOGY (2009)
Why is the neurobiology of nausea and vomiting so important?
Charles C. Horn
APPETITE (2008)
Subtype Selectivity in Phosphodiesterase 4 (PDE4): A Bottleneck in Rational Drug Design
P. Srivani et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Critical role of PDE4D in β2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts
Matthew D. Bruss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation
Elaine Huston et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B)
Han-Ting Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2008)
L-454,560, a potent and selective PDE4 inhibitor with in vitro efficacy in animal models of asthma and cognition
Z. Huang et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells:: Predominant role of PDE4D
Daniel Peter et al.
JOURNAL OF IMMUNOLOGY (2007)
cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system - A molecular toolbox for generating compartmentalized cAMP signaling
Miles D. Houslay et al.
CIRCULATION RESEARCH (2007)
Overview of PDEs and their regulation
Kenji Omori et al.
CIRCULATION RESEARCH (2007)
Antidepressant-like effects of PDE4 inhibitors mediated by the high-affinity rolipram binding state (HARBS) of the phosphodiesterase-4 enzyme (PDE4) in rats
HT Zhang et al.
PSYCHOPHARMACOLOGY (2006)
Improving memory: A role for phosphodiesterases
A. Blokland et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Phosphodiesterase-4 as a therapeutic target
MD Houslay et al.
DRUG DISCOVERY TODAY (2005)
Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages
SLC Jin et al.
JOURNAL OF IMMUNOLOGY (2005)
Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation
M Ariga et al.
JOURNAL OF IMMUNOLOGY (2004)
The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases
W Richter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antidepressant-induced increase in high-affinity Rolipram binding sites in rat brain: Dependence on noradrenergic and serotonergic function
Y Zhao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses
SLC Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Assessing the emetic potential of PDE4 inhibitors in rats
A Robichaud et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Motion sickness potentiates core cooling during immersion in humans
IB Mekjavic et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway
A Robichaud et al.
NEUROPHARMACOLOGY (2001)
Share Paper
